-

AHF Africa Applauds South Africa’s Approval of HIV Preventative Vaginal Ring

KAMPALA, Uganda--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) Africa Bureau welcomed today South Africa’s approval of the Dapivirine Vaginal Ring for use by women ages 18 and older as a step in the right direction in HIV prevention. The recommendation follows an announcement by the International Partnership for Microbicides (IPM)—developers of the vaginal ring—that its product had received a nod from the South African Health Products Regulatory Authority (SAHPRA).

According to the World Health Organisation (WHO), the DPV-VR is a silicone ring that gives women alternatives and control over reducing their risk of HIV infection. The ring, which should be worn inside the vagina, operates by gradually discharging the antiretroviral drug dapivirine into the vagina over a 28-day period to help protect women from HIV.

“This news that advances HIV prevention options and sexual reproductive health rights for women in South Africa could not have come at a better time than in the month we commemorate International Women’s Day and Women’s History; Especially for a demographic that is disproportionately affected by HIV in South Africa and Sub-Saharan Africa,” said Dr. Penninah Iutung, AHF Africa Bureau Chief.

“We know that unequal power dynamics contribute greatly to limiting many women’s ability to negotiate safer-sex or condom use, which puts them at risk of HIV,” Dr. Iutung added. “Thus, this approval by the South African government is a game-changer, as it offers women more biomedical HIV prevention choices that are female-initiated and long-acting, and we look forward to working with the government to bring the ring closer to South African women in the facilities and communities we serve.”

Since 2002, AHF has partnered with the South African government through its AHF South Africa Program to provide cutting-edge HIV treatment, care and support to more than 170,000 clients.

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation, the largest global AIDS organization, currently provides medical care and/or services to over 1.6 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

Contacts

SA MEDIA CONTACT:
Dr Nduduzo Dube, Acting Country Program Director
AHF South Africa
+27 (0)10 590 5530
Nduduzo.dube@ahf.org

AFRICA BUREAU MEDIA CONTACT:
Oluwakemi Gbadamosi, Director, Advocacy, Policy & Marketing
+234-91-21-500-600
Oluwakemi.gbadamosi@aidshealth.org

US MEDIA CONTACT:
Ged Kenslea, Senior Director
Communications, AHF
+1.323.308.1833 work
+1.323.791.5526 mobile
gedk@aidshealth.org

AIDS Healthcare Foundation


Release Summary
This approval by the South African government is a game-changer, as it offers women more biomedical HIV prevention choices that are female-initiated.
Release Versions

Contacts

SA MEDIA CONTACT:
Dr Nduduzo Dube, Acting Country Program Director
AHF South Africa
+27 (0)10 590 5530
Nduduzo.dube@ahf.org

AFRICA BUREAU MEDIA CONTACT:
Oluwakemi Gbadamosi, Director, Advocacy, Policy & Marketing
+234-91-21-500-600
Oluwakemi.gbadamosi@aidshealth.org

US MEDIA CONTACT:
Ged Kenslea, Senior Director
Communications, AHF
+1.323.308.1833 work
+1.323.791.5526 mobile
gedk@aidshealth.org

Social Media Profiles
More News From AIDS Healthcare Foundation

Latin America’s PAHO-Gilead HIV Prevention Deal Is a Victory for Civil Society, says AHF

MEXICO CITY--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), the world’s largest HIV care provider, welcomes a new agreement between Gilead Sciences and the Pan American Health Organization (PAHO) that could expand access to lenacapavir for HIV prevention in 14 countries across Latin America. The agreement represents a positive step toward expanding access in the region and a victory for civil society. AHF was among the first organizations to mobilize around concerns that the initial Gilead-...

AHF to Commemorate 40 Years of Global Impact During Annual World AIDS Day Concert Celebration

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), the world’s largest, non-profit public health organization providing direct HIV/AIDS services to over 3.3 million clients across the globe, will celebrate 40 years of impact during its annual World AIDS Day concert commemoration. The event, which is free and open to the public, is scheduled for the evening of Monday, November 30, 2026, at the Kia Forum in Inglewood, California. RSVP to AHFWAD.org for tickets. Commemorated annually...

Sexual Health Is Health: Testing, Treatment and Prevention for All, says AHF

LOS ANGELES--(BUSINESS WIRE)--As sexually transmitted infections continue to rise worldwide, AIDS Healthcare Foundation (AHF) marks World Sexual Health Day by calling on governments and health systems to expand access to prevention, testing, and treatment services for HIV and other STIs. Despite proven tools to prevent, diagnose, and treat HIV and other STIs, gaps in access continue to put millions of people at risk globally. With an estimated 1.2 million new HIV infections each year globally,...
Back to Newsroom